BEYOND AIR, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events.

On August 23, 2022, Beyond Air, Inc. (the "Company") issued a press release (the "Press Release") announcing that Beyond Cancer, Ltd., an affiliate of the Company, has treated the first patient in a first-in-human Phase 1 clinical trial to assess the safety and immune biomarkers of ultra-high concentration nitric oxide (UNO) therapy. A copy of the Press Release is attached hereto and incorporated herein by reference in its entirety as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                                Description
99.1            Press Release of Beyond Air, Inc. dated August 23, 2022.
104           Cover Page Interactive Data File (embedded within the inline XBRL
              document).

© Edgar Online, source Glimpses